BioCentury | Jun 17, 2013
Company News

Alliance Pharma, Novartis sales and marketing update

...Alliance's Alliance Pharmaceuticals Ltd. subsidiary acquired all rights to Syntometrine oxytocin/ergometrine from Novartis for $11.5 million...
BioCentury | Oct 30, 2006
Company News

Alliance Pharma, Novartis sales and marketing update

...rights to market NVS's Syntometrine oxytocin/ ergometrine in the U.K. for £2 million ($3.8 million). Syntometrine...
Items per page:
1 - 2 of 2